Pathogenic Potential to Humans of Bovine Escherichia coli O26, Scotland

This pathogen may be the next Shiga toxin–producing E. coli of concern.

[1]  R. Evans.  European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[2]  T. Beattie,et al.  Highly Virulent Escherichia coli O26, Scotland , 2011, Emerging infectious diseases.

[3]  S Morabito,et al.  Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  J. Pearson,et al.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements , 2011, Molecular microbiology.

[5]  K. Lynch,et al.  Verocytotoxin-producing and attaching and effacing activity of Escherichia coli isolated from diseased farm livestock , 2011, Veterinary Record.

[6]  G. Gunn,et al.  Prevalence of Escherichia coli O157: H7 and serogroups O26, O103, O111 and O145 in sheep presented for slaughter in Scotland. , 2011, Journal of medical microbiology.

[7]  L. Beutin,et al.  Human Infections with Non-O157 Shiga Toxin–producing Escherichia coli, Switzerland, 2000–2009 , 2011, Emerging infectious diseases.

[8]  D. Mellor,et al.  Associations between the Presence of Virulence Determinants and the Epidemiology and Ecology of Zoonotic Escherichia coli , 2010, Applied and Environmental Microbiology.

[9]  M. Woolhouse,et al.  Temporal and spatial patterns of bovine Escherichia coli O157 prevalence and comparison of temporal changes in the patterns of phage types associated with bovine shedding and human E. coli O157 cases in Scotland between 1998-2000 and 2002-2004 , 2009, BMC Microbiology.

[10]  F. Conraths,et al.  Analysis of the Clonal Relationship of Serotype O26:H11 Enterohemorrhagic Escherichia coli Isolates from Cattle , 2009, Applied and Environmental Microbiology.

[11]  David L Gally,et al.  Controlling injection: regulation of type III secretion in enterohaemorrhagic Escherichia coli. , 2009, Trends in microbiology.

[12]  M. Woolhouse,et al.  Super-shedding and the link between human infection and livestock carriage of Escherichia coli O157 , 2008, Nature Reviews Microbiology.

[13]  A. Mellmann,et al.  Analysis of Collection of Hemolytic Uremic Syndrome–associated Enterohemorrhagic Escherichia coli , 2008, Emerging infectious diseases.

[14]  G. Frankel,et al.  Attaching effacing Escherichia coli and paradigms of Tir‐triggered actin polymerization: getting off the pedestal , 2008, Cellular microbiology.

[15]  L. Beutin,et al.  Serotypes and virutypes of enteropathogenic and enterohaemorrhagic Escherichia coli strains from stool samples of children with diarrhoea in Germany , 2007, Journal of applied microbiology.

[16]  C. Jenkins,et al.  Escherichia coli serogroup O26 – a new look at an old adversary , 2007, Journal of applied microbiology.

[17]  A. Mellmann,et al.  Shiga Toxin Gene Loss and Transfer In Vitro and In Vivo during Enterohemorrhagic Escherichia coli O26 Infection in Humans , 2007, Applied and Environmental Microbiology.

[18]  K. Bettelheim.  The Non-O157 Shiga-Toxigenic (Verocytotoxigenic) Escherichia coli; Under-Rated Pathogens , 2007, Critical reviews in microbiology.

[19]  Daniel Falush,et al.  Sex and virulence in Escherichia coli: an evolutionary perspective , 2006, Molecular microbiology.

[20]  D. Mellor,et al.  Prevalence and Virulence Factors of Escherichia coli Serogroups O26, O103, O111, and O145 Shed by Cattle in Scotland , 2006, Applied and Environmental Microbiology.

[21]  A. Mellmann,et al.  Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  P. Tarr,et al.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.

[23]  J. Condon,et al.  Estimation of infection prevalence from correlated binomial samples. , 2004, Preventive veterinary medicine.

[24]  K. Bettelheim.  Non-O157 Verotoxin-Producing Escherichia coli: A Problem, Paradox, and Paradigm , 2003, Experimental biology and medicine.

[25]  A. Caprioli,et al.  Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk. , 2003, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[26]  T. Pysher,et al.  Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome , 2003, Pediatric Nephrology.

[27]  Yves Van de Peer,et al.  zt: A Sofware Tool for Simple and Partial Mantel Tests , 2002 .

[28]  T. Cheasty,et al.  Verocytotoxin-Producing Escherichia coli Serotype O26 : H11 Outbreak in an Irish Crèche , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[29]  H. Karch,et al.  Molecular Characteristics and Epidemiological Significance of Shiga Toxin-Producing Escherichia coliO26 Strains , 2000, Journal of Clinical Microbiology.

[30]  H. Karch,et al.  Antibacterials that are used as growth promoters in animal husbandry can affect the release of Shiga-toxin-2-converting bacteriophages and Shiga toxin 2 from Escherichia coli strains. , 2000, Microbiology.

[31]  H. Karch,et al.  Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. , 2000, Journal of clinical microbiology.

[32]  C. Harwood,et al.  Induction of type 2 Shiga toxin synthesis in Escherichia coli 0157 by 4-quinolones , 1999, The Lancet.

[33]  S. McEwen,et al.  Associations between Virulence Factors of Shiga Toxin-ProducingEscherichia coli and Disease in Humans , 1999, Journal of Clinical Microbiology.

[34]  J. Paton,et al.  Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. , 1998, Journal of clinical microbiology.

[35]  T. Cheasty,et al.  Vero cytotoxin-producing Escherichia coli O157 outbreaks in England and Wales, 1995: phenotypic methods and genotypic subtyping. , 1997, Emerging infectious diseases.

[36]  A. Caprioli,et al.  Non-O157 Shiga toxin-producing Escherichia coli infections in Europe. , 1997, Emerging infectious diseases.

[37]  J. Samuel,et al.  Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice , 1993, Infection and immunity.